You have full text access to this OnlineOpen article

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

August 2002

Volume 54, Issue 2

Pages 101–230

  1. Pharmacokinetics

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have full text access to this OnlineOpen article
      Pharmacokinetics of tibolone in early and late postmenopausal women (pages 101–106)

      C. J. Timmer, H. A. M. Verheul and D. P. Doorstam

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01619.x

    2. You have full text access to this OnlineOpen article
    3. You have full text access to this OnlineOpen article
    4. You have full text access to this OnlineOpen article
      Intestinal first pass metabolism of midazolam in liver cirrhosis – effect of grapefruit juice (pages 120–124)

      Vibeke Andersen, Natalie Pedersen, Niels-Erik Larsen, Jesper Sonne and Steen Larsen

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01615.x

    5. You have full text access to this OnlineOpen article
      Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis (pages 125–130)

      O. M. Takayanagui, P. S. Bonato, S. A. C. Dreossi and V. L. Lanchote

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01634.x

    6. You have full text access to this OnlineOpen article
      Relationships between body composition parameters and fluorouracil pharmacokinetics (pages 131–139)

      Milena Gusella, Sivia Toso, Eros Ferrazzi, Mariano Ferrari and Roberto Padrini

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01598.x

  2. Pharmacokinetics/pharmacodynamics

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have full text access to this OnlineOpen article
      An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria (pages 140–146)

      Angela Matthews, Trevor N. Johnson, Amin Rostami-Hodjegan, Anupam Chakrapani, J. Edward Wraith, Stuart J. Moat, James R. Bonham and Geoffrey T. Tucker

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01620.x

    2. You have full text access to this OnlineOpen article
      Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis (pages 147–156)

      Jaroslav Chládek, Jiøı´ Grim, Jiøina Martínková, Marie Šimková, Jaroslava Vanı`èková, Vı`ra Koudelková and Marie Noièková

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01621.x

  3. Drug disposition

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have full text access to this OnlineOpen article
      The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver (pages 157–167)

      Janet K. Coller, Niels Krebsfaenger, Kathrin Klein, Karin Endrizzi, Renzo Wolbold, Thomas Lang, Andreas Nüssler, Peter Neuhaus, Ulrich M. Zanger, Michel Eichelbaum and Thomas E. Mürdter

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01614.x

  4. Therapeutics

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have full text access to this OnlineOpen article
      Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa (pages 168–170)

      D. A. M. C. Van De Vijver, R. A. C. Roos, P. A. F. Jansen, A. J. Porsius and A. De Boer

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2001.01491.x

  5. Pharmacovigilance

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have full text access to this OnlineOpen article
      Non-antiarrhythmic drugs prolonging the QT interval:considerable use in seven countries (pages 171–177)

      Fabrizio De Ponti, Elisabetta Poluzzi, Alberto Vaccheri, Ulf Bergman, Lars Bjerrum, John Ferguson, Kerry J. Frenz, Peter McManus, Ingrid Schubert, Gisbert Selke, Georgia Terzis-Vaslamatzis and Nicola Montanaro

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01617.x

  6. Short report

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have full text access to this OnlineOpen article
      Interaction between saquinavir soft-gel and rifabutin in patients infected with HIV (pages 178–182)

      G. J. Moyle, N. E. Buss, T. Goggin, P. Snell, C. Higgs and D. A. Hawkins

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01631.x

  7. Letter to the Editors

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have free access to this content
  8. Book reviews

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have full text access to this OnlineOpen article
    2. You have full text access to this OnlineOpen article
      Complementary therapies for pharmacists (page 187)

      Trevor N. Johnson

      Article first published online: 4 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01645.x

  9. 3rd meeting on clinical measurement and new drug development

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/pharmacodynamics
    4. Drug disposition
    5. Therapeutics
    6. Pharmacovigilance
    7. Short report
    8. Letter to the Editors
    9. Book reviews
    10. 3rd meeting on clinical measurement and new drug development
    1. You have full text access to this OnlineOpen article
    2. You have full text access to this OnlineOpen article
    3. You have full text access to this OnlineOpen article
    4. You have full text access to this OnlineOpen article

SEARCH

SEARCH BY CITATION